サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514143

コンピュータ支援検出（CAD）の世界市場

Computer Aided Detection (CAD)
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 203 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.52円
コンピュータ支援検出（CAD）の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 203 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

コンピュータ支援検出（CAD）の世界市場は2030年までに20億米ドルに達する見込み

2023年に11億米ドルと推定されるコンピュータ支援検出（CAD）の世界市場は、分析期間2023-2030年にCAGR 9.1％で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるマンモグラフィ・モダリティは、CAGR 9.8%を記録し、分析期間終了時には7億5,900万米ドルに達すると予測されます。MRIモダリティ分野の成長率は、分析期間中CAGR 8.6％と推定されます。

米国市場は2億8,450万米ドルと推定、中国はCAGR12.3％で成長予測

米国のコンピュータ支援検出（CAD）市場は、2023年に2億8,450万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4億5,800万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは12.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.8%と7.3%と予測されています。欧州では、ドイツがCAGR約6.8%で成長すると予測されています。

世界のコンピュータ支援検出（CAD）市場- 主要動向と促進要因まとめ

高度なアルゴリズムと機械学習を活用したコンピュータ支援検出（CAD）システムは、医療画像を解釈し、さまざまな医療分野で診断精度を高める上で重要な役割を果たしています。これらのシステムは、X線、MRI、内視鏡、超音波などの画像から潜在的な異常を特定することで放射線科医を支援し、重要な診断支援を提供します。人工知能などの高度な技術の統合により、CADシステムはデジタル病理学、予防検診、緊急診断などの分野でますます不可欠なものとなっています。これらのシステムに対する需要の高まりは、特にがんのような複雑な領域において、早期発見と正確な診断をサポートすることによって患者の転帰を改善する能力によってもたらされています。

マンモグラフィやMRIなどの医療用画像処理技術の技術的進歩は、がんの有病率の上昇と相まって、CAD市場の主な促進要因となっています。これらの改良により、より精密で高解像度の画像が得られるようになり、CADソフトウェアがより正確な分析を行えるようになった。さらに、ヘルスケアにおけるクラウドコンピューティングへのシフトは、ITコストの削減と医療従事者間のコラボレーション強化を提供する、スケーラブルでアクセス可能なCADソリューションの開発を可能にしています。さまざまな診断機器からの画像を解析できるマルチモダリティCADシステムの動向は、診断精度と患者の転帰をさらに向上させる。

CADシステムにおけるAIの統合は、膨大なデータセットから学習し、がんなどの疾患を示す複雑なパターンや異常を認識するツールを提供することで、医療画像診断における重要な進化を意味します。このAIの統合は、診断を迅速化し、ヒューマンエラーを減少させ、予防ヘルスケアと早期診断に重点を置くようになっています。一般的な画像診断にとどまらず、CADシステムは、大腸内視鏡検査におけるポリープや、呼吸器内科における肺結節といった疾患の検出に特化した用途も見出しています。現在進行中の調査では、CADの革新はデジタル病理学にも進出しており、免疫染色だけでなく、標準的なH&E染色の分析など、より広範な診断作業への応用が拡大しています。

調査対象企業の例（全103社）

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6036

Global Computer Aided Detection (CAD) Market to Reach US$2.0 Billion by 2030

The global market for Computer Aided Detection (CAD) estimated at US$1.1 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end of the analysis period. Growth in the MRI Modality segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$284.5 Million While China is Forecast to Grow at 12.3% CAGR

The Computer Aided Detection (CAD) market in the U.S. is estimated at US$284.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$458.0 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

Select Competitors (Total 103 Featured) -

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Computer Aided Detection (CAD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cancer Drives Computer Aided Detection Market Growth
    • Need for Early Disease Detection Spur Adoption of CAD
    • Integration of AI and Machine Learning in CAD Systems Throws Spotlight on Innovation
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Market Growth
    • Increasing Demand for Automated Detection Solutions Drives Market Demand
    • Rising Investments in Cancer Research Expands Market Horizons
    • Growing Focus on Reducing Diagnostic Errors Spurs Adoption of CAD Systems
    • Increasing Use of CAD in Breast Cancer Screening Sustains Market Growth
    • Rising Demand for CAD in Lung Cancer Detection Here is the Story
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiovascular & Neurological Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Tomosynthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Computer Aided Detection (CAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • JAPAN
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CHINA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • EUROPE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • GERMANY
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • INDIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • AFRICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030

IV. COMPETITION